Terms: = Breast cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
366 results:
1. Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.
Demeule M; Currie JC; Charfi C; Zgheib A; Cousineau I; Lullier V; Béliveau R; Marsolais C; Annabi B
Front Immunol; 2024; 15():1355945. PubMed ID: 38482021
[TBL] [Abstract] [Full Text] [Related]
2. Relationship between immune checkpoint proteins and neoadjuvant chemotherapy response in breast cancer.
Kina Kilicaslan U; Aru B; Aydin Aksu S; Vardar Aker F; Yanikkaya Demirel G; Gurleyik MG
Surg Oncol; 2024 Feb; 52():102037. PubMed ID: 38290327
[TBL] [Abstract] [Full Text] [Related]
3. Integrin-associated transcriptional characteristics of circulating tumor cells in breast cancer patients.
Grigoryeva E; Tashireva L; Alifanov V; Savelieva O; Zavyalova M; Menyailo M; Khozyainova A; Denisov EV; Bragina O; Popova N; Cherdyntseva NV; Perelmuter V
PeerJ; 2024; 12():e16678. PubMed ID: 38250718
[TBL] [Abstract] [Full Text] [Related]
4. Isolation of Viable Epithelial and Mesenchymal Circulating Tumor Cells from breast cancer Patients.
Topa J; Żaczek AJ; Markiewicz A
Methods Mol Biol; 2024; 2752():43-52. PubMed ID: 38194026
[TBL] [Abstract] [Full Text] [Related]
5. Alterations in the mammary gland and tumor microenvironment of formerly obese mice.
Kuziel G; Moore BN; Haugstad GP; Xiong Y; Williams AE; Arendt LM
BMC Cancer; 2023 Dec; 23(1):1183. PubMed ID: 38041006
[TBL] [Abstract] [Full Text] [Related]
6. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
7. Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients.
Krawczyk N; Jaeger B; Martina PJ; Cristina LR; Melissa N; Maggie BP; Franziska MS; Hans N; Dieter N; Eugen R; Svjetlana M; Jürgen H; Thomas K; Irene E; Tanja F
Arch Gynecol Obstet; 2024 Apr; 309(4):1525-1533. PubMed ID: 37902839
[TBL] [Abstract] [Full Text] [Related]
8. [Treatment of paclitaxel and doxorubicin changes the immune microenvironment of breast cancer and inhibits the growth of tumor cells in mice].
Wang R; Lang L; Chen S; Wan X; Hou Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):891-897. PubMed ID: 37882712
[TBL] [Abstract] [Full Text] [Related]
9. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
[TBL] [Abstract] [Full Text] [Related]
10. NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells.
Campos-Mora M; Jacot W; Garcin G; Depondt ML; Constantinides M; Alexia C; Villalba M
Front Immunol; 2023; 14():1199594. PubMed ID: 37593736
[TBL] [Abstract] [Full Text] [Related]
11. TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through cd45 receptor.
Raiter A; Lipovetsky J; Stenbac A; Lubin I; Yerushalmi R
Oncoimmunology; 2023; 12(1):2246322. PubMed ID: 37593677
[TBL] [Abstract] [Full Text] [Related]
12. Safety and efficacy of left colic artery preservation in laparoscopic anterior resection for lower rectal cancer.
Li Z; Zhou Y; Xu L; Xie L
Future Oncol; 2023 Jul; 19(21):1485-1494. PubMed ID: 37466013
[No Abstract] [Full Text] [Related]
13. A PDA-Functionalized 3D Lung Scaffold Bioplatform to Construct Complicated breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy.
Zhang W; Chen Y; Li M; Cao S; Wang N; Zhang Y; Wang Y
Adv Sci (Weinh); 2023 Sep; 10(26):e2302855. PubMed ID: 37424037
[TBL] [Abstract] [Full Text] [Related]
14. ptprc promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
Li P; Wang W; Wang S; Cao G; Pan T; Huang Y; Wan H; Zhang W; Huang Y; Jin H; Wang Z
Front Immunol; 2023; 14():1145481. PubMed ID: 37388747
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
[TBL] [Abstract] [Full Text] [Related]
16. The effect of acute exercise on circulating immune cells in newly diagnosed breast cancer patients.
Koivula T; Lempiäinen S; Rinne P; Rannikko JH; Hollmén M; Sundberg CJ; Rundqvist H; Minn H; Heinonen I
Sci Rep; 2023 Apr; 13(1):6561. PubMed ID: 37085562
[TBL] [Abstract] [Full Text] [Related]
17. Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Carter JM; Chumsri S; Hinerfeld DA; Ma Y; Wang X; Zahrieh D; Hillman DW; Tenner KS; Kachergus JM; Brauer HA; Warren SE; Henderson D; Shi J; Liu Y; Joensuu H; Lindman H; Leon-Ferre RA; Boughey JC; Liu MC; Ingle JN; Kalari KR; Couch FJ; Knutson KL; Goetz MP; Perez EA; Thompson EA
Nat Commun; 2023 Apr; 14(1):2215. PubMed ID: 37072398
[TBL] [Abstract] [Full Text] [Related]
18. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
19. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
[TBL] [Abstract] [Full Text] [Related]
20. Simultaneous isolation of cd45 tumor-infiltrating lymphocytes, tumor cells, and associated fibroblasts from murine breast tumor model by MACS.
Kalfeist L; Petit S; Galland L; Ghiringhelli F; Ladoire S; Limagne E
STAR Protoc; 2023 Mar; 4(1):101951. PubMed ID: 36856770
[TBL] [Abstract] [Full Text] [Related]
[Next]
